Tuberculosis has resurged dramatically in recent years in the United States. An estimated 51,700 excess tuberculosis cases have been recorded through 1992. Commensurate with the rise in tuberculosis frequency, an increase in the isolation of Mycobacterium tuberculosis strains resistant to one or more antibiotics commonly used as treatment has occurred. Together, these disease trends represent a clear and present danger to society. The long term goal of the proposed studies is to develop DNA-based diagnostic strategies for rapid identification and drug susceptibility testing of M. tuberculosis in primary clinical samples such as sputum. Specifically, the aims of the research are to, (i) Employ automated DNA sequencing to rapidly and unambiguously define the type and frequency distribution of mutations in several genes strongly associated with resistance to anti-tuberculosis medications, including rifampin, isoniazid, ethionamide, streptomycin, and ciprofloxacin. (ii) Explore the ability of an emerging technology, termed """"""""sequencing by hybridization,"""""""" or """"""""matrix sequencing,"""""""" to rapidly diagnose tuberculosis and identify mutations associated with drug resistance in primary clinical specimens and early positive cultures. (iii) Test the feasibility of using automated DNA sequencing strategies to rapidly diagnose tuberculosis and infections caused by mycobacteria other than tuberculosis, by characterization of species-specific allelic polymorphism in the structural gene (hsp65) encoding a heat shock protein, and identify mutations associated with drug resistance in M. tuberculosis. Both primary clinical specimens and early positive cultures will be used in the context of a busy hospital mycobacteriology diagnostic laboratory. Successful accomplishment of the proposed research will demonstrate the capability of diagnosing infection with M. tuberculosis, and other mycobacterial species, and identifying drug resistant M. tuberculosis strains in primary specimens in less than 24-hours.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI037004-05
Application #
2672414
Study Section
Special Emphasis Panel (SRC (85))
Project Start
1994-09-30
Project End
1999-12-31
Budget Start
1998-08-01
Budget End
1999-12-31
Support Year
5
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Baylor College of Medicine
Department
Pathology
Type
Schools of Medicine
DUNS #
074615394
City
Houston
State
TX
Country
United States
Zip Code
77030
Harris Jr, K A; Mukundan, U; Musser, J M et al. (2000) Genetic diversity and evidence for acquired antimicrobial resistance in Mycobacterium tuberculosis at a large hospital in South India. Int J Infect Dis 4:140-7
Musser, J M; Amin, A; Ramaswamy, S (2000) Negligible genetic diversity of mycobacterium tuberculosis host immune system protein targets: evidence of limited selective pressure. Genetics 155:16-Jul
Zhou, J; Dong, Y; Zhao, X et al. (2000) Selection of antibiotic-resistant bacterial mutants: allelic diversity among fluoroquinolone-resistant mutations. J Infect Dis 182:517-25
Ramaswamy, S V; Amin, A G; Goksel, S et al. (2000) Molecular genetic analysis of nucleotide polymorphisms associated with ethambutol resistance in human isolates of Mycobacterium tuberculosis. Antimicrob Agents Chemother 44:326-36
Frothingham, R; Strickland, P L; Bretzel, G et al. (1999) Phenotypic and genotypic characterization of Mycobacterium africanum isolates from West Africa. J Clin Microbiol 37:1921-6
Swanson, D S; Pan, X; Kline, M W et al. (1998) Genetic diversity among Mycobacterium avium complex strains recovered from children with and without human immunodeficiency virus infection. J Infect Dis 178:776-82
Ramaswamy, S; Musser, J M (1998) Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuber Lung Dis 79:3-29
Basso, L A; Zheng, R; Musser, J M et al. (1998) Mechanisms of isoniazid resistance in Mycobacterium tuberculosis: enzymatic characterization of enoyl reductase mutants identified in isoniazid-resistant clinical isolates. J Infect Dis 178:769-75
Kurepina, N E; Sreevatsan, S; Plikaytis, B B et al. (1998) Characterization of the phylogenetic distribution and chromosomal insertion sites of five IS6110 elements in Mycobacterium tuberculosis: non-random integration in the dnaA-dnaN region. Tuber Lung Dis 79:31-42
Escalante, P; Ramaswamy, S; Sanabria, H et al. (1998) Genotypic characterization of drug-resistant Mycobacterium tuberculosis isolates from Peru. Tuber Lung Dis 79:111-8

Showing the most recent 10 out of 32 publications